Difficulties and reflections on proper treatments of hepatoblastoma in children

References:

[1] Hafberg E,Borinstein SC,Alexopoulos SP.Contemporary management of hepatoblastoma[J].Curr Opin Organ Transplant,2019,24(2):113-117.DOI:10.1097/MOT.0000000000000618.
[2] 儿童肝母细胞瘤诊疗规范(2019年版)编写审定专家组.儿童肝母细胞瘤诊疗规范(2019年版)[J].临床肝胆病杂志,2019,35(11):2431-2434.DOI:10.3969/j.issn.1001-5256.2019.11.008. Expert Group for Drafting and Approving Guidelines for Diagnosing and Treating Hepatoblastoma (2019 Edition):Guidelines for Diagnosing and Treating Hepatoblastoma (2019)[J].J Clin Hepatol,2019,35(11):2431-2434.DOI:10.3969/j.issn.1001-5256.2019.11.008.
[3] Hou JY,Yeh TC,Huang TH,et al.A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma:a single institution experience[J].Pediatr Neonatol,2021,62(4):400-405.DOI:10.1016/j.pedneo.2021.03.018.
[4] Tian Y,Chen XH,Yu F,et al.Neoadjuvant chemotherapy or upfront surgery in hepatoblastoma:a multicenter retrospective study[J].Pediatr Blood Cancer,2023,70(9):e30470.DOI:10.1002/pbc.30470.
[5] Hu HM,Zhang WL,Li J,et al.Clinical application of irinotecan combined with first-line chemotherapeutics against pediatric hepatoblastoma with pulmonary metastasis[J].Pak J Pharm Sci,2022,35(5):1301-1306.
[6] Zhang YT,Feng LH,Zhong XD,et al.Vincristine and irinotecan in children with relapsed hepatoblastoma:a single-institution experience[J].Pediatr Hematol Oncol,2015,32(1):18-25.DOI:10.3109/08880018.2014.909913.
[7] Thompson PA,Malogolowkin MH,Furman WL,et al.Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma:a report from the Children’s Oncology Group AHEP0731 Study Committee[J].Pediatr Blood Cancer,2023,70(7):e30365.DOI:10.1002/pbc.30365.
[8] Hu HM,Zhang WL,Zhang Y,et al.Individualized chemotherapy and efficacy analysis of hepatoblastoma in children[J].Pediatr Blood Cancer,2024,71(1):e30693.DOI:10.1002/pbc.30693.
[9] Failli M,Demir S,Del Río-?lvarez ?,et al.Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response[J/OL].Hepatology,2023.https://doi.org/10.1097/hep.0000000000000601.DOI:10.1097/HEP.0000000000000601.
[10] Jiang YZ,Zhou SY,Shen G,et al.Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children[J].Medicine (Baltimore),2018,97(42):e12607.DOI:10.1097/MD.0000000000012607.
[11] Tang XL,He XB,Jiang H.Efficacy and safety of HIFU in combination with TACE in unresectable pediatric HB:a randomized,controlled,single-center clinical trial[J].Medicine (Baltimore),2022,101(48):e32022.DOI:10.1097/MD.0000000000032022.
[12] 中国抗癌协会肝癌专业委员会.肝动脉灌注化疗治疗肝细胞癌中国专家共识(2021版)[J].中华消化外科杂志,2021,20(7):754-759.DOI:10.3760/cma.j.cn115610-20210618-00288. Chinese Society of Liver Cancer,China Anti-Cancer Association:Chinese Expert Consensus on Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma (2021 Edition)[J].Chin J Dig Surg,2021,20(7):754-759.DOI:10.3760/cma.j.cn115610-20210618-00288.
[13] Liu S,Feng J,Ren QH,et al.Evaluating the clinical efficacy and limitations of indocyanine green fluorescence-guided surgery in childhood hepatoblastoma:a retrospective study[J].Photodiagnosis Photodyn Ther,2023,44:103790.DOI:10.1016/j.pdpdt.2023.103790.
[14] Paraboschi I,De Coppi P,Stoyanov D,et al.Fluorescence imaging in pediatric surgery:state-of-the-art and future perspectives[J].J Pediatr Surg,2021,56(4):655-662.DOI:10.1016/j.jpedsurg.2020.08.004.
[15] Meyers RL,Tiao G,de Ville de Goyet J,et al.Hepatoblastoma state of the art:pre-treatment extent of disease,surgical resection guidelines and the role of liver transplantation[J].Curr Opin Pediatr,2014,26(1):29-36.DOI:10.1097/MOP.0000000000000042.
[16] Yang TY,Whitlock RS,Vasudevan SA.Surgical management of hepatoblastoma and recent advances[J].Cancers (Basel),2019,11(12):1944.DOI:10.3390/cancers11121944.
[17] Aronson DC,Weeda VB,Maibach R,et al.Microscopically positive resection margin after hepatoblastoma resection:what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report[J].Eur J Cancer,2019,106:126-132.DOI:10.1016/j.ejca.2018.10.013.
[18] Ren XH,Li HB,Diao M,et al.Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy:a retrospective cohort study[J].Int J Clin Oncol,2020,25(4):765-773.DOI:10.1007/s10147-019-01573-0.
[19] Fuchs J,Murtha-Lemekhova A,Rabaux-Eygasier L,et al.Evidence on indications and techniques to increase the future liver remnant in children undergoing extended hepatectomy:a systematic review and meta-analysis of individual patient data[J].Front Pediatr,2022,10:915642.DOI:10.3389/fped.2022.915642.
[20] 姚伟,董岿然,肖现民,等.联合肝脏离断和门静脉结扎二步肝切除术治疗儿童肝母细胞瘤一例报告[J].中华小儿外科杂志,2018,39(8):597-603.DOI:10.3760/cma.j.issn.0253-3006.2018.08.009. Yao W,Dong KR,Xiao XM,et al.Associating liver partition and portal vein ligation for staged hepatectomy for hepatoblastoma:a report of one case[J].Chin J Pediatr Surg,2018,39(8):597-603.DOI:10.3760/cma.j.issn.0253-3006.2018.08.009.
[21] Wu YH,Zeng LX,Qiu RL,et al.Two-stage laparoscopic resection of giant hepatoblastoma in infants combined with liver partial partition and artery ligation[J].World J Surg Oncol,2021,19(1):63.DOI:10.1186/s12957-021-02156-y.
[22] 余辉,郑百俊,高亚,等.全腹腔镜ALPPS治疗小儿巨块型肝脏肿瘤[J].临床小儿外科杂志,2021,20(7):635-640,657.DOI:10.12260/lcxewkzz.2021.07.008. Yu H,Zheng BJ,Gao Y,et al.Total laparoscopic ALPPS in the treatment of massive liver tumor[J].J Clin Ped Sur,2021,20(7):635-640,657.DOI:10.12260/lcxewkzz.2021.07.008.
[23] Cai YL,Song PP,Tang W,et al.An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence[J].Medicine (Baltimore),2016,95(24):e3941.DOI:10.1097/MD.0000000000003941.
[24] Ye QF,Zeng C,Wang YF,et al.Long-term outcomes of ante-situm resection and auto-transplantation in conventionally unresectable hepatocellular carcinoma:a single-center experience[J].Ann Transplant,2018,23:81-88.DOI:10.12659/aot.905983.
[25] 康权,李英存,戴小科,等.体外循环辅助下半离体肝切除自体肝移植治疗儿童复杂肝脏肿瘤[J].中华小儿外科杂志,2018,39(10):725-728.DOI:10.3760/cma.j.issn.0253-3006.2018.10.002. Kang Q,Li YC,Dai XK,et al.Ex vivo hepatic resection and autotransplantation with cardiopulmonary bypass for hepatoblastoma in children:one case report[J].Chin J Pediatr Surg,2018,39(10):725-728.DOI:10.3760/cma.j.issn.0253-3006.2018.10.002.
[26] Hibi T,Rela M,Eason JD,et al.Liver transplantation for colorectal and neuroendocrine liver metastases and hepatoblastoma.Working group report from the ILTS transplant oncology consensus conference[J].Transplantation,2020,104(6):1131-1135.DOI:10.1097/TP.0000000000003118.
[27] Tang MJ,Ma XL,He XL,et al.A multicenter prospective study on the management of hepatoblastoma in children:a report from the Chinese Children’s Cancer Group[J/OL].World J Pediatr,2023,1-12.https://doi.org/10.1007/s12519-023-00750-6.DOI:10.1007/s12519-023-00750-6.
[28] Uchida H,Sakamoto S,Kasahara M,et al.An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan[J].Transpl Int,2021,34(8):1408-1421.DOI:10.1111/tri.13924.
[29] Boster JM,Superina R,Mazariegos GV,et al.Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma:experience from the Society of Pediatric Liver Transplantation (SPLIT)[J].Am J Transplant,2022,22(5):1396-1408.DOI:10.1111/ajt.16945.
[30] Xie HW,Liu G,Shen Z,et al.Surgical resection of chemotherapy-insensitive pulmonary metastases in children with hepatoblastoma in China:a single-center experience[J].J Cancer Res Ther,2022,18(5):1387-1391.DOI:10.4103/jcrt.jcrt_1992_21.
[31] Wu PV,Rangaswami A.Current approaches in hepatoblastoma-new biological insights to inform therapy[J].Curr Oncol Rep,2022,24(9):1209-1218.DOI:10.1007/s11912-022-01230-2.
[32] Lake CM,Bondoc AJ,Dasgupta R,et al.Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma[J].Cancer Med,2021,10(13):4322-4343.DOI:10.1002/cam4.3982.
[33] Li F,Zhang WL,Hu HM,et al.Factors influencing recurrence after complete remission in children with hepatoblastoma:a 14-year retrospective study in China[J].PLoS One,2021,16(11):e0259503.DOI:10.1371/journal.pone.0259503.
[34] Hiyama E,Hishiki T,Watanabe K,et al.Outcome and late complications of hepatoblastomas treated using the Japanese study group for pediatric liver tumor 2 protocol[J].J Clin Oncol,2020,38(22):2488-2498.DOI:10.1200/JCO.19.01067.
[35] 李潇然,叶进冬,赵頔,等.再次肝切除治疗复发性儿童肝母细胞瘤[J].中华普通外科杂志,2022,37(5):366-367.DOI:10.3760/cma.j.cn113855-20210616-00364. Li XR,Ye JD,Zhao D,et al.Re-hepatectomy for recurrent childhood hepatoblastoma[J].Chin J Gen Surg,2022,37(5):366-367.DOI:10.3760/cma.j.cn113855-20210616-00364.
[36] Takahashi N,Yamada Y,Hoshino K,et al.Living donor liver re-transplantation for recurrent hepatoblastoma in the liver graft following complete eradication of peritoneal metastases under indocyanine green fluorescence imaging[J].Cancers (Basel),2019,11(5):730.DOI:10.3390/cancers11050730.